Involvement of TNF-alpha secreting macrophages in lethal forms of human graft-versus-host disease

Bone Marrow Transplantation

Volumn 20, Issue 6, 1997, Pages 511-515

  Facon, T ^a   Jouet, J P ^a   Noel Walter, M P ^a   Bloget, F ^a   Bauters, F ^a   Janin, A ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Acute graft versus host disease; Macrophage; TNF alpha

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; LETHALITY; MACROPHAGE; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0030755330     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700912     Document Type: Article

References (21)

1. Lampert IA, Janossy G, Suitters AJ et al. Immunological analysis of the skin in graft-versus-host disease. Clin Exp Immunol 1982; 50: 123-131.
2. Guillen FJ, Ferrara J, Harcock W et al. Acute cutaneous graft-versus-host disease to minor histocompatibility antigens in a murine model: evidence that large granular lymphocytes are effector cells in the immune response. Lab Invest 1986; 55: 35-42.
3. Piguet PF. Tumor necrosis factor and graft-vs-host disease. In: SJ Burakoff, Deeg HJ, Ferrara J, Atkinson K (eds). Graft-vs-Host Disease: Immunology, Pathophysiology, and Treatment. Marcel Dekker: New York, 1990, pp 255-276.
4. Cuturi MC, Murphy M, Costa-Giomi MP et al. Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J Exp Med 1987; 165: 1581-1594.
5. Degliantoni G, Murphy M, Kobayashi M et al. Natural killer (NK) cell derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon. J Exp Med 1985; 162: 1512-1530.
6. Young JDE, Liu CC, Butler G et al. Identification, purification and characterisation of a mast cell-associated cytolytic factor related to tumor necrosis factor. Proc Natl Acad Sci USA 1987; 184: 9175-9179.
7. Piguet PF, Grau GE, Alht B, Vassalli P. Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs-host disease. J Exp Med 1987; 166: 1280-1289.
8. Cohen J. Cytokines as mediators of graft-vs-host disease. Bone Marrow Transplant 1988; 3: 193-197.
9. Piguet PF, Grau GE, Collant MA et al. Pneumopathies of the graft-versus-host-reaction: alveolitis associated with an increased level of TNF mRNA and chronic interstitial pneumonitis. Lab Invest 1989; 61: 37-45.
10. Holter E, Kollo HJ, Möller A et al. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood 1990; 75: 1011-1016.
11. Symington FW, Sullivan Pepe M, Chen AB, Deliganis A. Serum tumor necrosis factor alpha associated with acute graft-versus-host disease in humans. Transplantation 1990; 50: 518-521.
12. Grebe SC, Streilein JW. Graft-versus-host reactions. Adv Immunol 1976: 22: 185-221.
13. 1 graft-versus-host reaction. Immunogenic 1984; 20: 71-81.
14. Le J, Vilcek J. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab Invest 1987; 56: 234-248.
15. 1 hybrid mice. Br J Exp Pathol 1961; 42: 78-82.
16. Cooper GN, Howard JG. An effect of the graft-versus-host reaction on resistance to experimental bacteraemia. Br J Exp Pathol 1961; 42: 558-563.
17. Nestel FP, Price NS, Seemayer TA, Lapp WS. Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease. J Exp Med 1992; 175: 405-413.
18. Niederwieser DM, Herold W, Woloszezuk W et al. Endogenous IFN-gamma during human bone marrow transplantation: analysis of serum levels of interferon and interferon-dependent secondary messages. Transplantation 1990; 50: 620-625.
19. Storb R, Thomas ED. Graft-versus-host disease in dog and man: the Seattle experience. Immunol Rev 1985; 88: 215-238.
20. Burjes D, Hardt C, Deusch K. Studies of the mechanism of action of cyclosporine A in the murine and human T cell respectively, in vitro. In: White DJG (ed). Cyclosporine A. Elsevier: Amsterdam, 1982, pp 261-270.
21. Granelli-Piperno A, Keane M, Steinman RM. Evidence that cyclosporine inhibits cell-mediated immunity primarily at the level of the T lymphocyte rather than the accessory cell. Transplantation 1988; 46: 53-58.